Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBrief Communications

Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies

Paola A. Erba, Martina Sollini, Enrico Orciuolo, Claudio Traino, Mario Petrini, Giovanni Paganelli, Emilio Bombardieri, Chiara Grana, Leonardo Giovannoni, Dario Neri, Hans D. Menssen and Giuliano Mariani
Journal of Nuclear Medicine June 2012, 53 (6) 922-927; DOI: https://doi.org/10.2967/jnumed.111.101006
Paola A. Erba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Sollini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enrico Orciuolo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio Traino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Petrini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni Paganelli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emilio Bombardieri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chiara Grana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonardo Giovannoni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dario Neri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans D. Menssen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giuliano Mariani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 53 (6)
Journal of Nuclear Medicine
Vol. 53, Issue 6
June 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
Paola A. Erba, Martina Sollini, Enrico Orciuolo, Claudio Traino, Mario Petrini, Giovanni Paganelli, Emilio Bombardieri, Chiara Grana, Leonardo Giovannoni, Dario Neri, Hans D. Menssen, Giuliano Mariani
Journal of Nuclear Medicine Jun 2012, 53 (6) 922-927; DOI: 10.2967/jnumed.111.101006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
Paola A. Erba, Martina Sollini, Enrico Orciuolo, Claudio Traino, Mario Petrini, Giovanni Paganelli, Emilio Bombardieri, Chiara Grana, Leonardo Giovannoni, Dario Neri, Hans D. Menssen, Giuliano Mariani
Journal of Nuclear Medicine Jun 2012, 53 (6) 922-927; DOI: 10.2967/jnumed.111.101006
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE STATEMENT
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade
  • Targeted Delivery of IL2 to the Tumor Stroma Potentiates the Action of Immune Checkpoint Inhibitors by Preferential Activation of NK and CD8+ T Cells
  • Antibody-Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity
  • TGF-{beta} induces oncofetal fibronectin that, in turn, modulates TGF-{beta} superfamily signaling in endothelial cells
  • Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
  • Therapeutic vaccination targeting the tumour vasculature
  • Curative Properties of Noninternalizing Antibody-Drug Conjugates Based on Maytansinoids
  • Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET Study
  • Google Scholar

More in this TOC Section

  • Intraarterial Administration Boosts 177Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
  • Head-to-Head Comparison of 68Ga-NOTA (68Ga-NGUL) and 68Ga-PSMA-11 in Patients with Metastatic Prostate Cancer: A Prospective Study
  • Assessment of P-Glycoprotein Transport Activity at the Human Blood–Retina Barrier with (R)‐11C-Verapamil PET
Show more Brief Communications

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire